إعلان
إعلان

CAI

C

Caris Life Sciences, Inc. Common Stock

28.80
USD
برعاية
+0.42
+1.48%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

28.93

+0.13
+0.44%

تقارير أرباح CAI

النسبة الإيجابية المفاجئة

CAI تفوق 1 من 2 آخر التقديرات.

50%

التقرير التالي

بيانات التقرير القادم
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q-- -1 (Revenue/ EPS)
--
/
--

Caris Life Sciences, Inc. Common Stock earnings per share and revenue

On ٠٥ نوفمبر ٢٠٢٥, CAI reported earnings of 0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 138.66% surprise. Revenue reached 216.83 مليون, compared to an expected 171.86 مليون, with a 26.17% difference. The market reacted with a -15.75% price change (close before vs. close after earnings).
Looking ahead to -- --, -- المحللين forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Caris Life Sciences, Inc. Common Stock reported EPS of $0.08, beating estimates by 138.66%, and revenue of $216.83M, 26.17% above expectations.
The stock price moved down -15.75%, changed from $29.21 before the earnings release to $24.61 the day after.
The next earning report is scheduled for --.
Based on -- المحللين, Caris Life Sciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان